Insights into testosterone recovery after androgen deprivation therapy for prostate cancer

A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy (ADT) in men undergoing radiotherapy for prostate cancer, providing key insights for optimizing patient care.

NewAmsterdam hits primary endpoint in latest Phase 3 trial of CETP inhibitor

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 11, 2024

New Medicare Advantage rule is boon for providers, drag on insurers

Starting this year, private Medicare plans have to cover their members’ hospitalizations at the higher inpatient rate if their doctors predict they’ll have to stay

February 5, 2024

Opinion | We’ve Done Away With a Critical Source of Drug Use Data

Berger is a public health and behavioral health program coordinator. More than 2 years before COVID-19, HHS declared a public health emergency for opioid-related overdoses.

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.